Terms: = Testicular cancer AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1 AND Treatment
5 results:
1. Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a vegfr2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial.
Subbiah V; Meric-Bernstam F; Mills GB; Shaw KR; Bailey AM; Rao P; Ward JF; Pagliaro LC
J Hematol Oncol; 2014 Aug; 7():52. PubMed ID: 25085632
[TBL] [Abstract] [Full Text] [Related]
2. Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer.
Nitzsche B; Gloesenkamp C; Schrader M; Hoffmann B; Zengerling F; Balabanov S; Honecker F; Höpfner M
Br J Cancer; 2012 Nov; 107(11):1853-63. PubMed ID: 23169338
[TBL] [Abstract] [Full Text] [Related]
3. Novel compounds with antiangiogenic and antiproliferative potency for growth control of testicular germ cell tumours.
Nitzsche B; Gloesenkamp C; Schrader M; Ocker M; Preissner R; Lein M; Zakrzewicz A; Hoffmann B; Höpfner M
Br J Cancer; 2010 Jun; 103(1):18-28. PubMed ID: 20551952
[TBL] [Abstract] [Full Text] [Related]
4. Tyrosine kinase expression in pulmonary metastases and paired primary tumors.
Muehling BM; Toelkes S; Schelzig H; Barth TF; Sunder-Plassmann L
Interact Cardiovasc Thorac Surg; 2010 Feb; 10(2):228-31. PubMed ID: 19948538
[TBL] [Abstract] [Full Text] [Related]
5. CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients.
Salnikov AV; Gladkich J; Moldenhauer G; Volm M; Mattern J; Herr I
Int J Cancer; 2010 Feb; 126(4):950-8. PubMed ID: 19676044
[TBL] [Abstract] [Full Text] [Related]
